Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects

被引:0
作者
Lydia A Afman
Karin J A Lievers
Nathalie M J van der Put
Frans J M Trijbels
Henk J Blom
机构
[1] University Medical Center Nijmegen,Department of Pediatrics
[2] Laboratory of Pediatrics and Neurology,undefined
[3] P.O. Box 9101,undefined
[4] Unilever Research Vlaardingen,undefined
来源
European Journal of Human Genetics | 2002年 / 10卷
关键词
transcobalamin; vitamin B12; homocysteine; neural tube defects;
D O I
暂无
中图分类号
学科分类号
摘要
Homocysteine levels are elevated in mothers of neural tube defect (NTD) children, which may be due to a disturbed folate or vitamin B12 metabolism. Vitamin B12 is transported to the tissues by transcobalamin (TC). We previously showed that a low holo-TC/total-TC ratio is a risk factor for NTD, possibly due to an impaired binding of vitamin B12 to TC. The coding region of the TC gene of 12 individuals was analysed for genetic variations responsible for a disturbed vitamin B12 binding. The influence of the genetic variations observed on total-TC, holo-TC, holo-TC/total-TC, erythrocyte vitamin B12, plasma homocysteine concentrations and risk for NTD was explored in 42 mothers of a child with NTD and in 73 female controls. Direct sequencing analyses revealed five single nucleotide polymorphisms (SNPs). Three SNPs affected total-TC concentrations, whereas two SNPs seem to affect the binding of vitamin B12. None of the genotypes defined by the SNPs had a significant effect on homocysteine levels, or was associated with an increased NTD risk. Among the five SNPs observed only P259R could partly explain the reduced proportion of vitamin B12 bound to TC, which has been associated with an increased risk for having a child with NTD. Some of the variants studied affected total-TC and holo-TC/total-TC ratio but a larger study population is required to elucidate whether these SNPs influence delivery of vitamin B12 to the tissue, influence homocysteine levels and whether they are associated with an increased NTD risk.
引用
收藏
页码:433 / 438
页数:5
相关论文
共 68 条
[1]  
Czeizel AE(1992)Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation N Engl J Med 327 1832-1835
[2]  
Dudas I(1995)Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida Lancet 346 1070-1071
[3]  
van der Put NM(1994)Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 43 1475-1480
[4]  
Steegers-Theunissen RP(1997)Altered folate and vitamin B12 metabolism in families with spina bifida offspring QJM 90 505-510
[5]  
Frosst P(1995)Homocysteine metabolism in pregnancies complicated by neural-tube defects Lancet 345 149-151
[6]  
Steegers-Theunissen RP(1992)Maternal vitamin levels during pregnancies producing infants with neural tube defects J Pediatr 120 863-871
[7]  
Boers GH(1993)Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects QJM 86 703-708
[8]  
Trijbels FJ(1995)Neural tube defects and elevated homocysteine levels in amniotic fluid Am J Obstet Gynecol 172 1436-1441
[9]  
van der Put NM(1998)Neural-tube defects are associated with low concentrations of cobalamin (vitamin B12) in amniotic fluid Prenat Diagn 18 545-555
[10]  
Thomas CM(2001)Reduced vitamin B12 binding by transcobalamin II increases the risk of neural tube defects QJM 94 159-166